A phase 1b open-label study to evaluate the safety and tolerability of MEDI4736, an anti-PD-L1 antibody, in combination with tremelimumab in subjects with advanced non-small cell lung cancer Meeting Abstract


Authors: Pinder, M. C.; Rizvi, N. A.; Goldberg, S. B.; Balmanoukian, A. S.; Narwal, R.; Robbins, P. B.; D'Angelo, G.; Blake-Haskins, A.; Karakunnel, J. J.; Antonia, S. J.
Abstract Title: A phase 1b open-label study to evaluate the safety and tolerability of MEDI4736, an anti-PD-L1 antibody, in combination with tremelimumab in subjects with advanced non-small cell lung cancer
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613201344
PROVIDER: wos
Notes: Meeting Abstract: e19137^ -- Source: Wos
MSK Authors
  1. Naiyer A Rizvi
    157 Rizvi